Experimental Hematology
Volume 36, Issue 11 , Pages 1471-1479 , November 2008

Genetic profiling of myeloproliferative disorders by single-nucleotide polymorphism oligonucleotide microarray

  • Norihiko Kawamata

      Affiliations

    • Hematology/Oncology, Cedars-Sinai Medical Center/UCLA School of Medicine, Los Angeles, Calif., USA
    • Corresponding Author InformationOffprint requests to: Norihiko Kawamata, M.D., Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, 8700 Beverly Boulevard, Los Angeles, CA 90048
    • Drs. Kawamata and Ogawa contributed equally contributed to this work as the first authors.
    • ,
  • Seishi Ogawa

      Affiliations

    • Regeneration Medicine of Hematopoiesis, University of Tokyo, School of Medicine, Tokyo, Japan
    • Drs. Kawamata and Ogawa contributed equally contributed to this work as the first authors.
    • ,
  • Go Yamamoto

      Affiliations

    • Regeneration Medicine of Hematopoiesis, University of Tokyo, School of Medicine, Tokyo, Japan
    • ,
  • Soren Lehmann

      Affiliations

    • Hematology/Oncology, Cedars-Sinai Medical Center/UCLA School of Medicine, Los Angeles, Calif., USA
    • ,
  • Ross L. Levine

      Affiliations

    • Hematology, Brigham and Women's Hospital, Harvard University, School of Medicine, Boston, Mass., USA
    • ,
  • Yana Pikman

      Affiliations

    • Hematology, Brigham and Women's Hospital, Harvard University, School of Medicine, Boston, Mass., USA
    • ,
  • Yasuhito Nannya

      Affiliations

    • Regeneration Medicine of Hematopoiesis, University of Tokyo, School of Medicine, Tokyo, Japan
    • ,
  • Masashi Sanada

      Affiliations

    • Regeneration Medicine of Hematopoiesis, University of Tokyo, School of Medicine, Tokyo, Japan
    • ,
  • Carl W. Miller

      Affiliations

    • Hematology/Oncology, Cedars-Sinai Medical Center/UCLA School of Medicine, Los Angeles, Calif., USA
    • ,
  • D. Gary Gilliland

      Affiliations

    • Hematology, Brigham and Women's Hospital, Harvard University, School of Medicine, Boston, Mass., USA
    • ,
  • H. Phillip Koeffler

      Affiliations

    • Hematology/Oncology, Cedars-Sinai Medical Center/UCLA School of Medicine, Los Angeles, Calif., USA

Received 10 January 2008 ,Revised 11 June 2008 ,Accepted 17 June 2008.

References 

  1. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med. 2000;342:1255–1265
  2. Spivak JL. Diagnosis of the myeloproliferative disorders: resolving phenotypic mimicry. Semin Hematol. 2003;40(Suppl 1):1–5
  3. Thiele J, Kvasnicka HM, Orazi A. Bone marrow histopathology in myeloproliferative disorders—current diagnostic approach. Semin Hematol. 2005;42:184–195
  4. Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365:1054–1061
  5. James C, Ugo V, Le Couedic JP, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005;434:1144–1148
  6. Kralovics R, Passamonti F, Buser AS, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005;352:1779–1790
  7. Levine RL, Wadleigh M, Cools J, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell. 2005;7:387–397
  8. Zhao R, Xing S, Li Z, et al. Identification of an acquired JAK2 mutation in polycythemia vera. J Biol Chem. 2005;280:22788–22792
  9. Scott LM, Tong W, Levine RL, et al. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med. 2007;356:459–468
  10. Pikman Y, Lee BH, Mercher T, et al. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Med. 2006;3:e270
  11. Pardanani AD, Levine RL, Lasho T, et al. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood. 2006;108:3472–3476
  12. Levine RL, Belisle C, Wadleigh M, et al. X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis. Blood. 2006;107:4139–4141
  13. Garraway LA, Widlund HR, Rubin MA, et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature. 2005;436:117–122
  14. Kawamata N, Ogawa S, Zimmermann M, et al. Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high resolution single nucleotide polymorphism oligonucleotide genomic microarray. Blood. 2008;111:776–784
  15. Lehmann S, Ogawa S, Raynaud SD, et al. Molecular allelokaryotyping of early stage untreated chronic lymphocytic leukemia. Cancer. 2008;112:1296–1305
  16. Nannya Y, Sanada M, Nakazaki K, et al. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res. 2005;65:6071–6079
  17. Yamamoto G, Nannya Y, Kato M, et al. Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays. Am J Hum Genet. 2007;81:114–126
  18. Batard P, Sansilvestri P, Scheinecker C, et al. The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells. Blood. 1996;87:2212–2220
  19. Lannutti BJ, Shim MH, Blake N, Reems JA, Drachman JG. Identification and activation of Src family kinases in primary megakaryocytes. Exp Hematol. 2003;31:1268–1274
  20. Kaushansky K. The molecular mechanisms that control thrombopoiesis. J Clin Invest. 2005;115:3339–3347
  21. Carter NP. Methods and strategies for analyzing copy number variation using DNA microarrays. Nat Genet. 2007;39(Suppl):S16–S21
  22. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature. 2006;444:444–454
  23. Jakobsson M, Scholz SW, Scheet P, et al. Genotype, haplotype and copy-number variation in worldwide human populations. Nature. 2008;451:998–1003
  24. Sebat J, Lakshmi B, Troge J, et al. Large-scale copy number polymorphism in the human genome. Science. 2004;305:525–528
  25. Raghavan M, Lillington DM, Skoulakis S, et al. Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias. Cancer Res. 2005;65:375–378
  26. Kralovics R, Guan Y, Prchal JT. Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera. Exp Hematol. 2002;30:229–236

PII: S0301-472X(08)00303-2

doi: 10.1016/j.exphem.2008.06.006

Experimental Hematology
Volume 36, Issue 11 , Pages 1471-1479 , November 2008

Article Tools

* Image Usage & Resolution